The Vigabatrin REMS Program is required by the FDA to make sure informed risk-benefit choices prior to initiating therapy, and to guarantee proper use vigabatrin while people are treated. When vision loss will occur, it is not possible for your healthcare company to understand.
The most typical side effect of SABRIL in children 3 to 16 years is weight gain. With severe vision loss, you might only have the ability to see things right in front of you (occasionally called tunnel vision"). You go to risk for vision loss with any kind of amount of SABRIL.
If you are pregnant or plan to get expectant, inform your medical care service provider. If vision testing can not be done, your healthcare provider may proceed recommending SABRIL, but will not be able to watch for any type of vision loss. If vision tests are refrained frequently, your healthcare provider may quit suggesting SABRIL for you (or your kid).